Abstract
Magnesium sulfate (MgSO4) has been proposed to be an efficient treatment in persistent pulmonary hypertension of the newborn. We compared the ability of MgSO4 to inhibit the responses to several vasoconstrictors in isolated intrapulmonary and mesenteric arteries from 10-17-d-old piglets. MgSO4 (3-100 mM) produced a slight vasodilator effect in pulmonary arteries precontracted with the thromboxane A2 mimetic U46619(10-6 M), noradrenaline (10-5 M), and KCl (80 mM) (15.1 ± 3.7%; 20 ± 3.33%; 10.4 ± 0.9% at 100 mM MgSO4, respectively). In contrast, in mesenteric arteries MgSO4 produced a marked vasodilation (80.4 ± 4.0%, 93.1 ± 3.46%, and 87.5± 1.93% at 100 mM MgSO4, respectively, p < 0.01versus pulmonary arteries). The vasodilator effect of MgSO4 was endothelium-independent and reversed by increasing the extracellular Ca2+ concentration. After incubation for 1 h of pulmonary arteries with three different MgSO4 concentrations (0, 1.2, and 4.8 mM) there were no differences in the contractile responses to U46619 nor in the vasodilator effects of acetylcholine or sodium nitroprusside. Rapid removal of Mg2+ from bath medium produced a transient vasodilation which was more marked in pulmonary than in mesenteric arteries and was greatly reduced by the removal of endothelium or by the nitric oxide synthase inhibitor L-NAME (10-4 M). We conclude that MgSO4 is a poor vasodilator of pulmonary arteriesin vitro and at physiologic concentrations appears to inhibit nitric oxide release from the pulmonary endothelium. Thus, the possible beneficial clinical effects of MgSO4 in persistent pulmonary hypertension of the newborn do not seem to be related to a direct effect on pulmonary vascular smooth muscle.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
Abbreviations
- PPHN:
-
persistent pulmonary hypertension of the newborn
- [X]i:
-
X intracellular concentration
- [X]o:
-
X extracellular concentration
- TXA2:
-
thromboxane A2
- NO:
-
nitric oxide
- ACh:
-
acetylcholine
- NA:
-
noradrenaline
- SNP:
-
sodium nitroprusside
- VSM:
-
vascular smooth muscle
- U46619:
-
9,11-dideoxy-11α,9α-epoxymethano-prostaglandin F2α(TXA2 analog)
- L-NAME:
-
Nω-nitro-L-arginine methyl ester
References
Roberts JD, Shaul PW 1993 Advances in the treatment of persistent pulmonary hypertension of the newborn. Pediatr Clin North Am 40: 983–1004.
Ryan CA, Finer NN, Barrington KJ 1994 Effects of magnesium sulphate and nitric oxide in pulmonary hypertension induced by hypoxia in newborn piglets. Arch Dis Child 71:F151–F155.
Roberts JD Jr, Chen T, Wain J, Polaner D, Dupuy P, Zapol WM 1992 Nitric oxide gas is a selective pulmonary vasodilator in the newborn lamb during hypoxemia and acidosis. Pediatr Res 31:A1279.
Roberts JD, Polaner DM, Lang P, Zapol WM 1992 Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 340: 819–820.
Kinsella JP, Neish SR, Shaffer E, Abman SH 1992 Low-dose inhalational nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 340: 819–820.
Drummond WE, Lock JE 1984 Neonatal “pulmonary vasodilator” drugs. Dev Pharmacol Ther 7: 1–20.
Altura BT, Altura BM 1981 Magnesium ions and contraction of vascular smooth muscles: relationship to some vascular diseases. Fed Proc 40: 2672–1679.
Altura BM, Altura BT, Carella A, Gebrewold A, Murakawa T, Nishio A 1987 Mg2+-Ca2+ interaction in contractility of vascular smooth muscle: Mg2+ versus organic calcium channel blockers on myogenic tone and agonist-induced responsiveness of blood vessels. Can J Physiol Pharmacol 65: 729–745.
Iseri LT, French JH 1984 Magnesium: nature's physiological calcium blocker (Editorial). Am Heart J 108: 188–193.
Rüegg UT, Wallnofer A, Weir S, Cauvin C 1989 Receptor-operated calcium-permeable channels in vascular smooth muscle. J Cardiovasc Pharmacol 14( Suppl 6): S49–S58.
Gold ME, Buga GM, Wood KS, Byrns RE, Chaudhuri G, Ignarro LJ 1990 Antagonistic modulatory roles of magnesium and calcium on release of endothelium derived relaxing factor and smooth muscle tone. Circ Res 66: 355–366.
Ku DD, Ann HS 1987 Magnesium deficiency produces endothelium-dependent vasorelaxation in canine coronary arteries. J Pharmacol Exp Ther 241: 961–966.
Ku DD, Ann HS 1991 Differential effects of magnesium on basal and agonist-induced EDRF in canine coronary arteries. J Cardiovasc Pharmacol 17: 999–1006.
Flink EB, Dehdia HV, Dinsmore J, Doshi HM, Banks D, Hshieh P 1992 High-dose magnesium sulfate attenuates pulmonary oxygen toxicity. Crit Care Med 20: 1692–1698.
Nadler JL, Goodson S, Rude RK 1987 Evidence that prostacyclin mediates the vascular action of magnesium in humans. Hypertension 9: 379–383.
Abu-Osba YK, Rhydderck D, Balansundaram S, Galal O, Rejjal A, Halees Z, Duran C 1990 Reduction of hypoxia-induced pulmonary hypertension (HIPH) by MgSO4 in sheep. Pediatr Res 27: 351A
Anderson ME, Burnette TM, Geiser DR, Janjindamai W 1994 Magnesium attenuates pulmonary hypertension due to hypoxia and group B streptococci. J Appl Physiol 77: 751–756.
Abu-Osba YK, Galal O, Manasra K, Rejjal A 1992 Treatment of severe persistent pulmonary hypertension of the newborn with magnesium sulfate. Arch Dis Child 67: 31–35.
Tolsa J-F, Cotting J, Sekarski N, Payot M, Micheli J-L, Calame A 1995 Magnesium sulphate as an alternative and safe treatment for severe persistent pulmonary hypertension of the newborn. Arch Dis Child 72:F184–F187.
Perez-Vizcaino F, Casis O, Rodriguez R, Gomez LA, Garcia Rafanell J, Tamargo J 1993 Effects of the novel potassium channel opener, UR-8225, on contractile responses in rat isolated smooth muscle. Br J Pharmacol 110: 1165–1171.
Villamor E, Perez-Vizcaino F, Ruiz T, Leza JC, Moro M, Tamargo J 1995 Group B Streptococcus and E. coli LPS-induced NO-dependent hyporesponsiveness to noradrenaline in isolated intrapulmonary arteries of neonatal piglets. Br J Pharmacol 115: 261–266.
McLean RM 1994 Magnesium and its therapeutic uses: a review. Am J Med 96: 63–76.
Levy M, Tulloh RMR, Komai H, Stuart-Smith K, Haworth SG 1995 Maturation of the contractile response and its endothelial modulation in newborn porcine intrapulmonary arteries. Pediatr Res 38: 25–29.
D'Angelo EKG, Singer HA, Rembold CM 1992 Magnesium relaxes arterial smooth muscle by decreasing intracellular Ca2+ without changing intracellular Mg2+. J Clin Invest 89: 1988–1994.
Alborch E, Salom JB, Perales AJ, Torregrosa G, Miranda FJ, Alabadi JA, Jover T 1992 Comparison of the anticonstrictor action of dihydropyridines (nimodipine and nicardipine) and Mg2+ in isolated human cerebral arteries. Eur J Pharmacol 229: 83–89.
Dickstein PJ, Trintade O, Goldberg RN, Bancalari E 1984 The effect of calcium antagonists on hypoxic pulmonary hypertension in the piglet. Pediatr Res 18: 1262–1265.
Dobyns EL, Wescott JA, Kennaugh JM, Ross MN, Stenmark KR 1994 Eicosanoids decrease with successful extracorporeal membrane oxygenation therapy in neonatal pulmonary hypertension. Am J Respir Crit Care Med 149: 873–880.
Warner AE, Molina R, Brain JD 1987 Uptake of bloodborne bacteria by pulmonary intravascular macrophages and consequent inflammatory responses in sheep. Am Rev Respir Dis 136: 683–693.
Frostell C, Fratacci MD, Wain JC, Jones R, Zapol WM 1991 Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation 83: 2038–2047.
Altura BT, Altura BM 1987 Endothelium-dependent relaxation in coronary arteries requires magnesium ions. Br J Pharmacol 91: 449–451.
Farago M, Dora E, Horvath I, Szabo C, Kovach AGB 1989 Contractile and endothelium-dependent dilatory responses of cerebral and mesenteric arteries at various Mg2+ levels. J Vasc Med Biol 1: 85A
Author information
Authors and Affiliations
Additional information
Supported by a CICYT (92/0157) and a FIS (95/0308) Grants. E.V. is a recipient of the Asociación Española de Pediatría/Arbora S.A. Grant for Pediatric Research.
Rights and permissions
About this article
Cite this article
Villamor, E., Pérez-Vizcaíno, F., Ruiz, T. et al. In Vitro Effects of Magnesium Sulfate in Isolated Intrapulmonary and Mesenteric Arteries of Piglets. Pediatr Res 39, 1107–1112 (1996). https://doi.org/10.1203/00006450-199606000-00029
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1203/00006450-199606000-00029
This article is cited by
-
Effect of increasing doses of magnesium in experimental pulmonary hypertension after acute pulmonary embolism
Intensive Care Medicine (2004)
-
Involvement of protein kinase C in reduced relaxant responses to the NO/cyclic GMP pathway in piglet pulmonary arteries contracted by the thromboxane A2‐mimetic U46619
British Journal of Pharmacology (1997)
